Trending News
News
News
Protelica Awarded Phase II SBIR Grant by the National Science Foundation
The $500,000 grant will develop companies’ platform technology, and will fund preclinical studies of its candidates for cardiovascular and cancer therapies.
News
Wellcome Trust Centre for Human Genetics Selects GenoLogics Solution to Manage Sequencing Data
Wellcome Trust is deploying Geneus lab and data management solution for genomics, including integrations to next generation sequencing platforms.
News
Schering-Plough Licenses Symyx Notebook for Global R&D Operations
Schering-Plough and Symyx also collaborates to develop within the Symyx Notebook a commercial metrology module built on Symyx informatics platform.
News
Chinese Researchers Sequence World's First Giant Panda Genome
Using Illumina's genome analyzer, researchers at BGI, Shenzhen de novo sequence the giant panda genome.
News
Protein Forest Expands into Europe
The new European division will support sales, product demonstrations, applications development and collaborative projects with European customers.
News
Team Finds Breast Cancer Gene Linked to Disease Spread
Researchers identify a long-sought gene affecting 30 to 40 percent of all breast cancer patients that resists traditional chemotherapies and leads to death.
News
FASgen Announces Research and License Agreement with Centocor
Centocor to discover and develop novel small molecule inhibitors of the fatty acid biosynthesis pathway via selective inhibition of FAS for use in Oncology.
News
Vampires Go to Bat for Stroke Treatment
The stroke experts are hoping a blood thinner that mimics a chemical in vampire saliva will help save brain cells in stroke patients.
News
Brain Starvation as We Age Appears to Trigger Alzheimer’s
A slow, chronic starvation of the brain as we age appears to be one of the major triggers of a biochemical process that causes some forms of Alzheimer's disease.
News
Celera and Abbott Revise Strategic Alliance from Profit Sharing to Worldwide Distribution and Royalty Agreements
New agreements include distribution arrangement for certain Celera products and royalty-bearing arrangement for m2000™ sales.
Advertisement